TY  - CHAP
M1  - Book, Section
TI  - Immune-Related Adverse Events (irAEs) in Cancer Patients
A1  - Reynolds, Kerry
A1  - Ananthakrishnan, Ashwin
A1  - Dougan, Michael
A1  - Bardia, Aditya
A2  - McKean, Sylvia C.
A2  - Ross, John J.
A2  - Dressler, Daniel D.
A2  - Scheurer, Danielle B.
Y1  - 2017
N1  - 
T2  - Principles and Practice of Hospital Medicine, 2e
AB  - Key  Clinical  Questions  When  should  immune-related  adverse  events  (irAEs)  be  suspected  in  acutely  ill  hospitalized  oncology  patients?  How  do  you  evaluate  an  oncology  patient  who  may  have  an  irAE  related  to  immunotherapy  treatment?  How  do  you  manage  patients  with  irAEs?  What  should  you  consider  when  discharging  a  patient  that  has  been  treated  for  an  irAE?  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1137618815
ER  -